Post by
cabbieJBJ on Feb 19, 2021 10:30am
Acacia focus shift to diversification
Here is a Seeking Alpha article opining on ACTG's rapid rise in value this year. As we know, ACTG carried much the same albatros as QTRH - tarred with the patent-troll narrative and unable to shift the focus sufficiently to its diversification strategy. The author here pins the sharp rise in ACTG's stock price to its holdings in life sciences, specifically biotech. Due to ACTG's tie up with Starboard Value, they were able to made a big splash. Perhaps QTRH need to seriously re-evaluate a "big spash" now rather than wait and execute a series of solid strategic tuck-ins.
https://seekingalpha.com/article/4407247-acacia-research-corporation-next-generation-genomic-sequencing-at-a-bargain-price?mail_subject=actg-acacia-research-next-generation-genomic-sequencing-at-a-bargain-price&utm_campaign=rta-stock-article&utm_content=link-2&utm_medium=email&utm_source=seeking_alpha
Comment by
redcoats on Feb 20, 2021 1:32am
A heck of a lot of "Winners" on this board then, Wilander. Most know how extremely undervalued QTRH is, so they've been hanging in here for a long time.
Comment by
wilander on Feb 20, 2021 9:00am
I hear ya redcoats. I'm just finally hitting the wall of wait. I bet I am not alone.